13F Data
Security · CUSIP G46843119

IBERE PHARMACEUTICALS

*W EXP 03/01/202 · institutional ownership from 13F filings
13F holders
1
Shares held
0
Value held
$0
New / sold out
0 / 0
Added / reduced
0 / 0
net 0 shares

13F holders by quarter

Q2 2021: 21Q3 2021: 22Q4 2021: 31Q1 2022: 34Q2 2022: 38Q3 2022: 39Q4 2022: 34Q1 2023: 2Q2 2023: 1Q3 2023: 1Q4 2023: 1Q1 2024: 1Q2 2024: 1Q3 2024: 1Q4 2024: 1Q1 2025: 1Q2 2025: 1
Q2 2021Q2 2025

Net shares bought by existing holders

Q2 2021: 2.2MQ3 2021: 295.6KQ4 2021: 554.2KQ1 2022: 112.3KQ2 2022: 121.0KQ3 2022: 481.5KQ4 2022: -287.2KQ1 2023: -3.8MQ2 2023: -9.8KQ3 2023: 0Q4 2023: 0Q1 2024: 0Q2 2024: 0Q3 2024: 0Q4 2024: 0Q1 2025: 0Q2 2025: 0
Q2 2021Q2 2025

Top holders · Q2 2025

ManagerSharesValue% of portfolio
CONCOURSE FINANCIAL GROUP SECURITIES, INC.0$0–

Biggest buyers

Nothing to show.

Biggest sellers

Nothing to show.